These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8583877)

  • 1. MnPcS4: a new MRI contrast enhancing agent for tumor localisation in mice.
    Saini SK; Jena A; Dey J; Sharma AK; Singh R
    Magn Reson Imaging; 1995; 13(7):985-90. PubMed ID: 8583877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-free extracellular MR contrast agent for tumor imaging.
    Nofiele JT; Haedicke IE; Zhu Yle K; Zhang XA; Cheng HL
    J Magn Reson Imaging; 2015 Feb; 41(2):397-403. PubMed ID: 24399613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors.
    Kovar DA; Lewis MZ; River JN; Lipton MJ; Karczmar GS
    Magn Reson Med; 1997 Aug; 38(2):259-68. PubMed ID: 9256106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice.
    Ogan MD; Revel D; Brasch RC
    Invest Radiol; 1987 Oct; 22(10):822-8. PubMed ID: 3429177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a potential tumor-seeking manganese metalloporphyrin contrast agent in a mouse model.
    Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Sugiyama M; Takeda H; Saga T; Nakajima S; Sakata I
    Magn Reson Med; 2002 Mar; 47(3):549-53. PubMed ID: 11870842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): tumor enhancement agent for magnetic resonance imaging.
    Matsumura A; Shibata Y; Yamamoto T; Nakagawa K; Yasuda S; Nakajima S; Sakata I; Yoshizawa T; Nose T
    Neurol Med Chir (Tokyo); 1997 Apr; 37(4):327-31. PubMed ID: 9136556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton relaxation enhancement by manganese(III)TPPS4 in a model tumor system.
    Fiel RJ; Button TM; Gilani S; Mark EH; Musser DA; Henkelman RM; Bronskill MJ; van Heteren JG
    Magn Reson Imaging; 1987; 5(2):149-56. PubMed ID: 3586881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of manganese meso-sulfonatophenyl porphyrins: contrast-enhancing agents for tumors.
    Fiel RJ; Musser DA; Mark EH; Mazurchuk R; Alletto JJ
    Magn Reson Imaging; 1990; 8(3):255-9. PubMed ID: 2366638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen-induced MR signal changes in murine tumors.
    Peller M; Weissfloch L; Stehling MK; Weber J; Bruening R; Senekowitsch-Schmidtke R; Molls M; Reiser M
    Magn Reson Imaging; 1998 Sep; 16(7):799-809. PubMed ID: 9811145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
    Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
    Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results.
    Mäurer J; Strauss A; Ebert W; Bauer H; Felix R
    Melanoma Res; 2000 Feb; 10(1):40-6. PubMed ID: 10711639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of Gd-DOTA in magnetic resonance imaging of experimentally induced mammary tumors.
    Bonnet PA; Michel A; Fernandez JP; Cyteval C; Rifai A; Boucard M; Chapat JP; Lamarque JL
    Magn Reson Imaging; 1990; 8(1):71-7. PubMed ID: 2325520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma.
    Peng Q; Moan J
    Br J Cancer; 1995 Sep; 72(3):565-74. PubMed ID: 7669563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI.
    Zhang W; Chen Y; Guo DJ; Huang ZW; Cai L; He L
    Eur J Radiol; 2011 Sep; 79(3):369-74. PubMed ID: 21106316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.